Share
Market Research Report

AI-ENABLED ORGANOID DRUG SCREENING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Segmentation
  • By Organoid TypeTumor Organoids · Liver Organoids · Brain Organoids · Kidney Organoids · Other Organoids
  • By TechnologyAI-Based Image Analysis and Phenotypic Profiling · Machine Learning-Based Drug Response Prediction · High-Content Screening and Automated Analysis · Multi-Omics Data Integration
  • By ApplicationDrug Efficacy Screening · Drug Toxicity and Safety Assessment · Drug Discovery and Lead Optimization · Personalized Drug Response Prediction
  • By Therapeutic AreaOncology · Neurological Disorders · Gastrointestinal Diseases · Liver and Metabolic Diseases · Infectious Diseases · Others
  • By End UserPharmaceutical and Biotechnology Companies · Contract Research Organizations (CROs) · Academic and Research Institutes · Others
  • By GeographyNorth America · Europe · Asia Pacific · Latin America · Middle East · and Africa
  • Published In30 Oct 2026
  • Report CodeCMI10322
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026 - 2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Global AI-Enabled Organoid Drug Screening Market, By Organoid Type
      • Global AI-Enabled Organoid Drug Screening Market, By Technology
      • Global AI-Enabled Organoid Drug Screening Market, By Application
      • Global AI-Enabled Organoid Drug Screening Market, By Therapeutic Area
      • Global AI-Enabled Organoid Drug Screening Market, By End User
      • Global AI-Enabled Organoid Drug Screening Market, By Region
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Component Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Market Opportunities
    • Industry Trends
  4. Global AI-Enabled Organoid Drug Screening Market, By Organoid Type, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Tumor Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Liver Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Brain Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Kidney Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Other Organoids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  5. Global AI-Enabled Organoid Drug Screening Market, By Technology, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • AI-Based Image Analysis and Phenotypic Profiling
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Machine Learning-Based Drug Response Prediction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • High-Content Screening and Automated Analysis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Multi-Omics Data Integration
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  6. Global AI-Enabled Organoid Drug Screening Market, By Application, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Drug Efficacy Screening
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Drug Toxicity and Safety Assessment
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Drug Discovery and Lead Optimization
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Personalized Drug Response Prediction
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  7. Global AI-Enabled Organoid Drug Screening Market, By Therapeutic Area, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Neurological Disorders
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Gastrointestinal Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Liver and Metabolic Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Infectious Diseases
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  8. Global AI-Enabled Organoid Drug Screening Market, By End User, 2021-2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 - 2033
      • Segment Trends
    • Pharmaceutical and Biotechnology Companies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Contract Research Organizations (CROs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Academic and Research Institutions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  9. Global AI-Enabled Organoid Drug Screening Market, By Region, 2021 - 2033, Value (USD Mn)

    • Introduction
      • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
      • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, By Organoid Type, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Application, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Therapeutic Area, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
      • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
        • South Africa
        • North Africa
        • Central Africa
  10. Competitive Landscape

    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • STEMCELL Technologies Canada Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Corning Incorporated
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • MIMETAS B.V.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • InSphero AG
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Crown Bioscience, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CN Bio Innovations Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • DefiniGEN Limited
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Emulate, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
  11. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. References and Research Methodology

    • References
    • Research Methodology
    • About us

*Browse 32 market data tables and 28 figures on AI-Enabled Organoid Drug Screening Market' - Global forecast to 2033